12-08-2024 |
AH |
|
ATRA |
Atara Biotherapeutics |
37.00 |
-3.10 |
-1.25 |
0.00 |
Atara Biotherapeutics GAAP EPS of -$3.10 misses by $1.54, revenue of $28.64M misses by $8.45M [8/12/2024 5:34 PM] |
8.10 |
0.33 (4.25%) |
0.0 |
0.0 (0.00%) |
4.97 - 52.25 |
50,496 |
50,000 |
0 |
|
|
09-05-2024 |
AH |
|
ATRA |
Atara Biotherapeutics |
73.00 |
-0.23 |
-0.37 |
0.00 |
Atara Biotherapeutics GAAP EPS of -$0.23 beats by $0.02, revenue of $27.36M beats by $2.67M [5/9/2024 5:26 PM] |
0.5370 |
-0.01 (-1.61%) |
0.57 |
0.02 (4.43%) |
0.20 - 2.54 |
1,804,936 |
1,230,000 |
147,849 |
|
|
28-03-2024 |
PM |
|
ATRA |
Atara Biotherapeutics, Inc. |
68.28 |
-0.56 |
-0.61 |
-0.72 |
Atara Biotherapeutics GAAP EPS of -$0.56 misses by $0.03, revenue of $4.25M misses by $10.01M [3/28/2024 8:43 AM] |
0.7072 |
0.01 (1.03%) |
0.67 |
-0.03 (-3.73%) |
0.20 - 3.08 |
1,096,273 |
1,420,000 |
25,384 |
|
|
01-11-2023 |
PM |
|
ATRA |
Atara Biotherapeutics |
130.00 |
-0.66 |
-0.63 |
0.00 |
|
1.25 |
-0.04 (-2.71%) |
1.31 |
0.02 (1.55%) |
1.24 - 5.64 |
1,665,270 |
1,040,000 |
56,858 |
|
|
08-08-2023 |
AH |
|
ATRA |
Atara Biotherapeutics, Inc. |
225.34 |
-0.68 |
-0.64 |
-0.31 |
Atara Biotherapeutics GAAP EPS of -$0.68 misses by $0.01, revenue of $0.96M misses by $2.81M [8/8/2023 4:21 PM] |
1.88 |
-0.40 (-17.40%) |
2.25 |
-0.02 (-0.88%) |
1.45 - 5.94 |
1,182,594 |
1,350,000 |
13,406 |
|
|
08-05-2023 |
AH |
4:00 PM ET (May 8) |
ATRA |
Atara Biotherapeutics, Inc. |
265.73 |
-0.72 |
-0.40 |
-0.87 |
Atara Biotherapeutics GAAP EPS of -$0.72 misses by $0.36, revenue of $1.23M misses by $29.45M [5/8/2023 5:07 PM] |
2.44 |
-0.54 (-18.01%) |
2.94 |
-0.03 (-1.01%) |
2.19 - 9.34 |
3,054,222 |
1,280,000 |
857 |
|
|
08-02-2023 |
AH |
4:00 PM ET (Feb 8) |
ATRA |
Atara Biotherapeutics, Inc. |
490.52 |
-0.72 |
-0.46 |
-0.96 |
Atara Biotherapeutics GAAP EPS of -$0.72 misses by $0.30, revenue of $0.22M misses by $39.45M [2/8/2023 4:02 PM] |
4.76 |
-0.28 (-5.56%) |
4.80 |
-0.24 (-4.76%) |
2.83 - 16.07 |
1,087,059 |
900,000 |
8,044 |
|
|
08-11-2022 |
AH |
4:00 PM ET (Nov 8) |
ATRA |
Atara Biotherapeutics, Inc. |
438.78 |
-0.82 |
-0.78 |
-0.90 |
Atara Biotherapeutics GAAP EPS of -$0.82 misses by $0.03, revenue of $4.46M beats by $0.72M [11/8/2022 4:03 PM] |
3.88 |
-1.02 (-20.71%) |
4.68 |
-0.22 (-4.49%) |
2.83 - 18.85 |
1,118,662 |
1,120,000 |
2,055 |
|
|
08-08-2022 |
AH |
4:00 PM ET (Aug 8) |
ATRA |
Atara Biotherapeutics, Inc. |
300.77 |
-0.31 |
-0.91 |
-0.91 |
Atara Biotherapeutics GAAP EPS of $0.18 beats by $1.14, revenue of $51.58M beats by $45.05M [8/8/2022 4:19 PM] |
4.69 |
1.06 (29.20%) |
3.85 |
0.22 (6.06%) |
2.83 - 20.04 |
13,870,294 |
2,230,000 |
85,698 |
|
|
05-05-2022 |
AH |
4:05 PM ET (May 5) |
ATRA |
Atara Biotherapeutics, Inc. |
646.10 |
-0.87 |
-0.98 |
-0.86 |
Atara Biotherapeutics GAAP EPS of -$0.87 beats by $0.14, revenue of $7.31M beats by $2.98M [5/5/2022 4:39 PM] |
6.92 |
0.10 (1.47%) |
6.82 |
0.0 (0.00%) |
6.31 - 20.04 |
693,701 |
890,000 |
169,778 |
|
|
28-02-2022 |
AH |
4:00 PM ET (Feb 28) |
ATRA |
Atara Biotherapeutics, Inc. |
1,190 |
-0.96 |
-0.60 |
-0.95 |
Atara Biotherapeutics GAAP EPS of -$0.96 misses by $0.37, revenue of $7.55M misses by $27.59M [2/28/2022 4:12 PM] |
10.15 |
-2.70 (-21.01%) |
12.68 |
-0.17 (-1.32%) |
9.93 - 20.04 |
2,074,105 |
810,000 |
1,370 |
|
|
04-11-2021 |
PM |
7:30 AM ET (Nov 4) |
ATRA |
Atara Biotherapeutics, Inc. |
1,400 |
-0.90 |
-0.92 |
-0.92 |
Atara Biotherapeutics EPS beats by $0.06, beats on revenue [11/4/2021 7:35 AM] |
19.89 |
1.14 (6.08%) |
19.89 |
0.0 (0.00%) |
11.81 - 28.20 |
948,631 |
650,000 |
9,491 |
|
|
09-08-2021 |
AH |
4:00 PM ET (Aug 9) |
ATRA |
Atara Biotherapeutics, Inc. |
1,080 |
-0.91 |
-0.88 |
-1.14 |
Atara Biotherapeutics EPS beats by $0.02, misses on revenue [8/9/2021 4:03 PM] |
12.75 |
0.26 (2.08%) |
13.05 |
0.56 (4.48%) |
11.33 - 28.20 |
925,166 |
550,000 |
4,162 |
|
|
04-05-2021 |
AH |
4:05 PM ET (May 4) |
ATRA |
Atara Biotherapeutics, Inc. |
1,220 |
-0.86 |
-0.93 |
-1.20 |
Atara Biotherapeutics EPS beats by $0.08, beats on revenue [5/4/2021 4:27 PM] |
13.51 |
-0.14 (-1.03%) |
14.30 |
0.65 (4.76%) |
8.39 - 28.20 |
695,339 |
1,120,000 |
7,230 |
|
|
01-03-2021 |
AH |
4:00 PM ET (Mar 1) |
ATRA |
Atara Biotherapeutics, Inc. |
1,380 |
-0.95 |
-0.73 |
-1.36 |
Atara Biotherapeutics EPS misses by $0.17 [3/1/2021 4:11 PM] |
17.07 |
-0.04 (-0.20%) |
16.70 |
-0.40 (-2.37%) |
4.52 - 28.20 |
1,415,410 |
679,291 |
1,055 |
|
|
09-11-2020 |
AH |
4:00 PM ET (Nov 9) |
ATRA |
Atara Biotherapeutics, Inc. |
1,030 |
-0.92 |
-1.10 |
-1.31 |
Atara Biotherapeutics EPS beats by $0.16 [11/9/2020 4:02 PM] |
15.55 |
1.15 (7.99%) |
14.88 |
0.48 (3.33%) |
4.52 - 19.36 |
1,417,378 |
534,695 |
1,191 |
|
|
05-08-2020 |
AH |
4:00 PM ET (Aug 5) |
ATRA |
Atara Biotherapeutics, Inc. |
915.75 |
-1.14 |
-1.21 |
-1.60 |
Atara Biotherapeutics EPS in-line [8/5/2020 4:11 PM] |
12.74 |
0.03 (0.24%) |
13.50 |
0.79 (6.22%) |
4.52 - 19.36 |
401,018 |
778,283 |
6,623 |
|
|
06-05-2020 |
AH |
|
ATRA |
Atara Biotherapeutics, Inc. |
518.78 |
-1.20 |
-1.36 |
-1.44 |
|
0.0 |
0.0 (0.00%) |
0.0 |
0.0 (0.00%) |
0.0 - 0.0 |
0 |
0 |
0 |
|
|